NCT00003753View on ClinicalTrials.gov

Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Colorectal CancerMetastatic Cancer
Interventions
DRUG

dexamethasone

DRUG

floxuridine

DRUG

irinotecan hydrochloride

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003753 - Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer | Biotech Hunter | Biotech Hunter